vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in vTv Therapeutics Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +5 vs. Q2 2023
- Shares held
- 3.44M
- −71.1K (−2.0%) vs. Q2 2023
- Total value
- $1.65M
- −$954.7K (−36.7%) vs. Q2 2023
- New holders
- 6
- 3 more added
- Sold out
- 1
- 4 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.85M |
| Q4 2023 | 14 | $788.7K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $6.49M |
| Q3 2021 | 31 | $5.17M |
| Q2 2021 | 42 | $9.89M |
| Q1 2021 | 48 | $13.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 1,635,509 | $781.8K | 0.24% | 00.0% | Unchanged |
| Vanguard Group Inc | 939,623 | $449.1K | 0.00% | 00.0% | Unchanged |
| Pathstone Family Office, LLC | 242,937 | $116.1K | 0.00% | +242,937 | New |
| Geode Capital Management, LLC | 236,131 | $112.9K | 0.00% | −53,216−18.4% | Reduced |
| State Street Corp | 134,745 | $64.4K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 53,661 | $25.6K | 0.00% | −1,473−2.7% | Reduced |
| Northern Trust Corp | 50,416 | $24.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 33,442 | $16.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 30,450 | $14.6K | 0.00% | +30,450 | New |
| Simon Quick Advisors, LLC | 30,000 | $14.3K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 20,278 | $9.69K | 0.00% | −55,973−73.4% | Reduced |
| Millennium Management LLC | 10,580 | $5.06K | 0.00% | +10,580 | New |
| Focused Wealth Management, Inc | 10,000 | $4.78K | 0.00% | 00.0% | Unchanged |
| Strengthening Families & Communities, LLC | 6,884 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,000 | $1.91K | 0.00% | +1,940+94.2% | Added |
| Parallel Advisors, LLC | 1,500 | $717 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,449 | $692 | 0.00% | +220+17.9% | Added |
| Comerica Bank | 1,000 | $478 | 0.00% | +1,000 | New |
| Cornerstone Planning Group LLC | 750 | $359 | 0.00% | 00.0% | Unchanged |
| Sunbelt Securities, Inc. | 600 | $287 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 376 | $180 | 0.00% | +376 | New |
| BNP Paribas Arbitrage, SA | 329 | $157 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 34 | $16 | 0.00% | +34 | New |
| FMR LLC | 7 | $3 | 0.00% | −5,176−99.9% | Reduced |
| Royal Bank of Canada | 293 | $0 | 0.00% | +184+168.8% | Added |
| Veritable, L.P. | 0 | $0 | 0.00% | −242,937−100.0% | Sold out |